PulseAugur / Brief
EN
LIVE 10:50:03

Brief

last 24h
[4/4] 224 sources

Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.

  1. TOOL · arXiv cs.AI English(EN) ·

    EyeMVP: OCT-Informed Fundus Representation Learning via Paired CFP--OCT Pretraining

    Researchers have developed EyeMVP, a novel foundation model for retinal image analysis that integrates data from both color fundus photography (CFP) and optical coherence tomography (OCT). Pretrained on a large dataset of paired CFP-OCT images from over 112,000 patients, EyeMVP learns to enhance CFP representations with OCT-derived structural information. This allows for more accurate diagnoses using only CFP images during inference, showing improved performance on tasks like macular edema and myopic macular schisis detection compared to existing models and human ophthalmologists in exploratory studies. AI

  2. TOOL · 36氪 (36Kr) 中文(ZH) ·

    Bio-Gene: Subsidiary's innovative drug SGC001 injection's new indication clinical trial application accepted

    热景生物's subsidiary, Shun Jing Medicine, has received approval for its innovative drug SGC001 injection to undergo clinical trials for an additional indication: severe acute pancreatitis. This drug has already received clinical approval from the FDA and CDE for emergency treatment of acute myocardial infarction, with Phase II trials underway. The acceptance of this new indication signifies a significant step in the drug's multi-indication clinical development. AI

    IMPACT This development in drug development may indicate future applications of AI in accelerating multi-indication trials.

  3. COMMENTARY · Mastodon — fosstodon.org English(EN) ·

    Hey, are you submitting CFPs that are written by LLMs? Just fuckin don't. Reviewers can easily tell, and if youre not going to put in effort for a CFP then your

    Submitting conference proposals written by large language models is strongly discouraged. Reviewers can readily identify AI-generated content, and such submissions suggest a lack of genuine effort from the applicant. This perceived lack of commitment can negatively impact the chances of acceptance. AI

    IMPACT Submitting AI-generated content for conferences may lead to rejection, signaling a need for authentic human effort in professional submissions.

  4. COMMENTARY · 36氪 (36Kr) 中文(ZH) ·

    Caibai Stock: Mingpai Industrial terminates share reduction plan early, no shares actually reduced

    Zhejiang Mingpai Industrial Co., Ltd. has decided to terminate its plan to reduce its stake in Caibai Co., Ltd., having not sold any shares. Concurrently, Shun Jing Pharmaceutical, a subsidiary of Rejebio, has received approval from China's National Medical Products Administration for a clinical trial of its innovative drug SGC001 injection. This drug, previously approved by the FDA and CDE for acute myocardial infarction treatment, will now also be investigated for severe acute pancreatitis. AI